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ABSTRACT
Objective: To study the effect of admixing intralipid (IL) with sodium chloride (NaCl) 0.9% infusion solution or Ringer’s solution (RS) on physical 
stability of IL.
Methods: Incompatibility test was done in two methods of admixture, i.e. in one container (1:1) and through three-way stopcock (1:2). They were 
observed for 24 hrs on its emulsion type, pH, microscopic observation of lipid globules, and globules size.
Results: The results of admixing IL and electrolyte solution (NaCl or RS) in one container and through three-way stopcock showed no changes in color 
and emulsion type (O/W). Physical stability evaluation results of IL and NaCl admixture in one container and through three-way stopcock showed 
that the pH value was 5.1 and 5.2, respectively, and microscopic observation of lipid globules and its size showed coalescence on 24 hrs with size 
625.16 nm (one container) and stable during 24 hrs (three-way stopcock). Physical stability evaluation results of IL and RS admixture in one container 
and through three-way stopcock showed that the pH value was 4.9 and 5.1, respectively, and microscopic observation of lipid globules and its size 
showed coalescence on 12 hrs with size 572.81 nm (one container) and flocculation on 24 hrs with size 558.12 nm (three-way stopcock).
Conclusion: Admixing electrolyte solution (NaCl or RS) and IL in one container and through three-way stopcock causes the larger globule size of IL.
Keywords: Intralipid 20%, Sodium chloride 0.9% infusion solution, Ringer’s solution, Physical stability.
INTRODUCTION
Patients in intensive care unit with various and complex conditions 
receive numerous intravenous (IV) medications. Frequently, the 
number of IV medication is more than that of venous access lumens for 
these patients. Therefore, coadministration of IV medications through 
the same line is done [1]. More than one IV medication increases the risk 
of incompatibility [2]. However, this situation is poorly understood by 
health staff [1]. The risks of incompatibility on patients are particulate 
emboli, tissue irritation, and therapeutic failure [3]. Several researchers 
have also studied the incompatibility of injection [4,5].
Parenteral nutrition is used when gastrointestinal tracts cannot be 
accessed and administered depending on patient’s condition [6]. 
Components of parenteral nutrition include amino acid, carbohydrate, 
lipid, vitamins, trace elements, and electrolyte [7]. Lipid emulsion is 
important component in parenteral nutrition [8].
Parenteral nutrition solutions are prepared in two forms: 2-in-1 (amino 
acid and carbohydrate) and 3-in-1 (amino acid, carbohydrate, and 
lipid) [9]. Advantages of admixing all nutrients in one container provide 
more convenience for administration, efficient for pharmacy personnel 
and storage, cheaper, lessen microbe contamination, usage of medical 
equipment, and monitoring time by nurse [10]. The total parenteral 
nutrition (3-in-1) that contains lipid tends to cause physical instability 
with the presence of electrolyte, especially polyvalent cation [11].
Malnutrition continues to be a major health burden in developing 
countries (for example, Indonesia) and the most important risk factor 
for illness and death [12,13]. Therapy for malnutrition patients is 
started with treatment or prevention of hypoglycemia, hypothermia, 
and dehydration. Hypoglycemia is treated with administration of 
dextrose 10% infusion solution [14]. Severe malnutrition is also 
characterized by essential fatty acid deficiency [13] and is treated by IV 
lipid emulsion [16]. Electrolyte imbalance is treated by administering 
Darrow’s solution, lactated Ringer’s solution (RS), and 0.45% sodium 
chloride (NaCl) [14].
The previous study by Driscoll et al. [17] was done evaluating the 
stability of amino acid, glucose, and electrolyte solution admixture with 
various formulations of lipid emulsion 20% which was combination of 
sunflower oil:soybean oil (1:1) (F1); only soybean oil (F2); mixture of 
soybean oil:middle chain triglyceride (1:1) (F3); and mixture of olive 
oil:soybean oil (4:1) (F4). F1 and F2 used egg lecithin as emulsifier, 
but F3 and F4 used egg lecithin and sodium oleate. Preparation 
of admixture was done aseptically and it was analyzed in room 
temperature for 5 times in interval of 30 hrs. The results showed that 
all formulas were unstable between 8 and 24 hrs, and each admixture 
showed increment of lipid globules and contained lipid globules which 
sized 5 µm. The research by Cocchio et al. [18] was done by admixing 
IV lipid emulsion with IV medications through Y-site in ratio 1:1 and 
the results of PFAT5 (proportion of enlarged droplets >5 µm) were 
significantly higher.
Stable IV lipid emulsion contains small droplets with size 200-500 nm. 
Droplet size ≥5 μm may cause lipid emboli when it enters blood 
stream [19]. Lipid emboli are occurred on lungs and brain that can 
cause acute respiratory failure and brain damage, simple anxiety until 
coma and death [20].
Based on the explanations above, researcher studied the effect of 
electrolyte solution (NaCl or RS) on physical stability of intralipid (IL) 
such as alteration in particle size.
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MATERIALS AND METHODS
Materials
IL(Fresenius Kabi, Jakarta, Indonesia), NaCl (PT. Widatra Bhakti, 
Pasuruan, Indonesia), RS (PT. Widatra Bhakti, Pasuruan, Indonesia), 
methylene blue, neutral buffer pH 7.01 (Hanna), acid buffer pH 4.01 
(Hanna) and distilled water.
Methods
Admixing in one container
Admixing NaCl and IL
NaCl was admixed with IL in ratio 1:1 (12.5:12.5 ml) on room 
temperature. Then, it was connected with infusion set with flow rate 1 
drop/6 seconds, and the admixture result was collected in glass bottle 
and then its physical stability was evaluated.
Admixing RS and IL
RS was admixed with IL in the same ratio and method as stated for 
admixing NaCl and IL in one container.
Admixing through three-way stopcock
Admixing NaCl and IL
IL was admixed with NaCl through three-way stopcock in ratio 
1:2 (12.5:25 ml) on room temperature with NaCl flow rate was 
1 drop/second while IL flow rate was 1 drop/6 seconds. Both infusion 
sets were connected to three-way stopcock; the admixture result was 
collected in glass bottle and then its physical stability was evaluated.
Admixing RS and IL
IL was admixed with RS through three-way stopcock with the same 
ratio and method as stated admixing NaCl and IL through three-way 
stopcock. RS flow rate was 2 drops/second.
Physical stability evaluation of NaCl or RS and IL admixture in 
one container or through three-way stopcock
Emulsion type evaluation
A drop of emulsion from admixture result was placed on object glass 
and then a drop of methylene blue was added. After that, the admixture 
was homogenized and closed with another object glass.
pH determination
pH of admixture was determined using pH meter.
Visual observation of lipid globules
Physical appearance evaluation was done within 0, 20, 40, 60 minutes, 
3, 6, 12 and 24 hrs with the help of a magnifiying glass.
Microscopic observation of lipid globules
Lipid globules morphology evaluation was done using digital 
microscope within 0, 20, 40, 60 minutes, 3, 6, 12 and 24 hrs.
Lipid globules size observation
Globules size evaluation was examined using particle size analyzer 
(Vascoγ) within 0, 12, and 24 hrs.
RESULTS
Admixing IL and electrolyte solution (NaCl or RS) in one container
IL is a white color emulsion. The results of admixing IL and electrolyte 
solution (NaCl or RS) in one container showed no changes in color.
Admixing IL and electrolyte solution (NaCl or RS) through three-
way stopcock
The results of admixing IL and electrolyte solution (NaCl or RS) through 
three-way stopcock was emulsion with white color too.
Physical stability evaluation of NaCl or RS and IL admixture in one 
container or through three-way stopcock
Emulsion type evaluation
As shown in Table 1, it can be observed that admixtures showed no 
emulsion phase changes during observation time.
pH determination
As shown in Table 2, it can be observed that pH of IL reduced when 
it was admixed with electrolyte solution. One container admixture and 
calcium-containing admixture (admixture with RS) had lower pH than 
other admixtures.
Visual and microscopic observation of lipid globules
Observation of lipid globules microscopically was done after admixture 
re-dispersed. Fig. 1a shows no enlargement of lipid globules, and it can 
be concluded that admixture is stable. Admixtures that showed physical 
instability (coalescence) are shown in Fig. 1b-d, which were marked by 
enlargement of lipid globules. Fig. 1e shows flocculation.
Lipid globules size observation
As shown in Table 3, it was shown that IL and admixtures of IL with 
electrolyte solution (NaCl or RS) have lipid droplet size >400 nm which 
is included in conventional emulsion [34]. From Table 3, it was shown 
that IL+NaCl in one container 24 hrs, IL+RS in one container 12 and 
24 hrs, and IL+RS through three-way stopcock 12 and 24 hrs showed 
instability due to lipid globules size ˃500 nm [27].
As shown in Table 3, it can be observed that one container admixtures 
showed larger lipid globules size than that of admixing through three-
way stopcock and also lipid globules size increased on admixture that 
contained RS. The longer the time after admixing, the larger the lipid 
globules size. This is caused by due to the longer contact time of positive 
ion with negative charge of phospholipid so that more lipid globules 
will unite become larger globules.
Lipid globules’ size distribution of IL and admixtures of IL and 
electrolyte solution (NaCl or RS) on 24 hrs is shown in Fig. 2a-e. The 
Table 1: Results of emulsion type evaluation
Time Emulsion type
IL IL + NaCl (1:1) one 
container
IL + RS (1:1) one 
container
IL + NaCl (1:2) three-way stopcock IL + RS (1:2) three-way stopcock
0 minute O/W O/W O/W O/W O/W
20 minutes O/W O/W O/W O/W O/W
40 minutes O/W O/W O/W O/W O/W
60 minutes O/W O/W O/W O/W O/W
3 hrs O/W O/W O/W O/W O/W
6 hrs O/W O/W O/W O/W O/W
12 hrs O/W O/W O/W O/W O/W
24 hrs O/W O/W O/W O/W O/W
IL: Intralipid, RS: Ringer’s solution, NaCl: Sodium chloride
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DISCUSSION
Emulsion type
O/W emulsion type is usually given parenterally [22] because blood 
contains blood cell suspension in plasma solution that has lots of 
water [21] so that O/W emulsion type is more soluble in blood fluid 
and more acceptable to the patient.
Physical appearance showed that during 24 hrs, IL which was admixed 
with electrolyte solution (NaCl or RS) showed coalescence process. 
This process did not cause phase inversion because the used emulsifier 
is dissolved in continuous phase (water) which leads to difficulty 
occurrence of phase inversion for higher volume ratio (water) [23]. 
Emulsifier in IL is purified phospholipid which the majority contains 
nonpolar lecithin. However, if lecithin contacts with water, it is hydrated 
to form emulsion [24]. In other words, the used emulsifier is soluble in 
water and inversion phase is difficult to occur.
pH determination
pH value of IL was obtained 7 while pH value that was stated on product 
label is ±8 with the adjustment of NaOH aqueous solution. This is caused 
by when IV lipid emulsion was produced before sterilization, and 
the pH was adjusted until approximately 8 [25]. Autoclaving process 
decreases pH and leads to phospholipid hydrolysis to lysophospholipid 
and free fatty acid so that this process reduces pH to 7 and this value 
is still acceptable by body [26] and meets the requirements of IV lipid 
emulsion pH in USP [27]. Slightly alkali condition will cause amphoteric 
characteristics of lecithin to form negative charge so that the surface 
charge increases. It also forms thicker bilayer phospholipid films which 
could form smaller droplet size, increase stability, and had favorable 
effect in plasma clearance. Na+ in NaOH formed sodium soaps with free 
fatty acids and stabilized the submicron emulsion by acting as auxiliary 
emulsifiers [28].
pH value of other admixtures had lower value than IL and the lowest 
was shown by RS which was admixed with IL in one container, i.e., 4.9. 
Lower pH was caused by pH of NaCl and RS itself was low so admixture of 
IL with NaCl or RS would definitely have lower pH. Lower pH (<5) must 
be avoided because electrostatic repulsive force among lipid globules 
lessen and causes globules size enlargement and coalescence [25].
Monovalent cations (Na+ and K+) bind with phosphate groups from 
phosphatidylcholine and reduce zeta potential of emulsion. Multivalent 
cation (Ca2+) adsorbs hydrophilic parts of phospholipid molecule and 
reduces zeta potential. Zeta potential becomes smaller with the increasing 
electrolyte concentration as a result of shrinkage of the electrical double 
layer at high ionic strength [29]. Based on Debye-Hückel equation, ionic 
strength of RS (0.158) is higher than NaCl (0.154) [30].





IL+NaCl (1:1) 1 container 5.1
IL+RS (1:1) 1 container 4.9
IL+NaCl (1:2) three-way 5.3
IL+RS (1:2) three-way 5.1
IL: Intralipid, RS: Ringer’s solution, NaCl: Sodium chloride
largest particle distribution is shown in Fig. 2c. which has the longest 
tail of distribution and the highest intensity peak.
As shown in Table 4, it can be seen that IL+NaCl in one container 
(24 hrs), IL+RS in one container (12 and 24 hrs), and IL+RS through 
three-way stopcock (12 and 24 hrs) showed particle size more than 
1 µm. IL+RS through three-way stopcock (12 and 24 hrs) showed slower 
enlargement in size. IL showed a little increment of lipid globules size 
on 24 hrs due to a little alteration of temperature during observation. 
The temperature may alterate the size of globules. Nevertheless, the 
observation was not done in controlled room temperature.
Fig. 1: Microscopic lipid globules observation. (a) Initial; 
(b) intralipid (IL)+sodium chloride (NaCl) in one container 
(24 hrs); (c) IL+Ringer’s solution (RS) in one container (12 hrs); 




Fig. 2: (a) Lipid globules size distribution of Intralipid (IL) (24 hrs). (b) Lipid globules size distribution of IL which was mixed with sodium 
chloride (NaCl) in one container (24 hrs). (c) Lipid globules size distribution of IL which was mixed with Ringer’s solution (RS) in one 
container (24 hrs). (d) Lipid globules size distribution of IL which was mixed with NaCl through three-way stopcock (24 hrs). (e) Lipid 
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Table 3: Results of admixture lipid globules size
Time (hrs) Lipid globules size (D mean intensity) (nm)
IL IL+NaCl (1:1) one 
container
IL+RS (1:1) one 
container
IL+NaCl (1:2) three-way stopcock IL+RS (1:2) three-way stopcock
0 447.16 450.73 457.54 445.99 440.56
12 457.33 475.12 572.81 471.51 539.56
24 485.11 625.16 992.37 490.89 558.12
IL: Intralipid, RS: Ringer’s solution, NaCl: Sodium chloride
Table 4: Results of admixture lipid globules size range
Time (hrs) Admixture lipid globules size range (nm)
IL IL+NaCl (1:1) one 
container
IL+RS (1:1) one 
container
IL+NaCl (1:2) three-way stopcock IL+RS (1:2) three-way stopcock
0 186.26-891.49 177.88-891.49 195.04-933.5 195.04-891.49 195.04-891.49
12 204.23-891.49 234.49-891.49 233.49-1230.59 204.23-933.5 223.93-1122.32
24 195.04-1023.56 269.22-1288.59 537.17-1778.75 245.54-891.49 223.93-1175.21
IL: Intralipid, RS: Ringer’s solution, NaCl: Sodium chloride
Visual and microscopic observation of lipid globules
Largest lipid globules microscopically are shown in Fig. 1d due to 
admixtures of IL and RS in one container. RS contains divalent ion (Ca2+) 
which is more disruptive than monovalent ions (Na+ and dan K+) [32]. 
Electrolyte with divalent charge (Ca2+) bonds strongly with lipid droplet 
that is stabilized with lecithin to form ion–lipid complex 1:2 so that 
it forms positive charge [30]. Lipid globules enlargement is caused 
by coalescence process that can be seen on its physical appearance. 
Coalescence occurs when lipid droplet was close, thin layer of water 
between two close droplets ruptures and causes oil from two droplets 
combine to form larger droplets [33]. Admixtures of IL and NaCl also 
showed enlargement of lipid globules although it was not as high as 
admixtures with RS.
IL and electrolyte solution (NaCl or RS) admixture through three-
way stopcock achieves more stable condition than admixture in one 
container as shown in Fig. 1e (flocculation phenomenon) due to the 
fact that interaction time of both solutions is in shorter time and lots 
amount of electrolyte solution have been flowed and the remained 
will interact with lipid globules of IL. Flocculation happens when 
oil suspended droplet collides due to naturally Brownian motion or 
agitation. Because of some collisions, attractive force (Van der Waals 
interaction) occurs between lipid globules because its surface has flaw 
so that attractive force exceeds repulsion force and causes droplet close 
to one another [33].
Lipid globules size observation
Lipid globules size for admixtures that contain RS showed larger 
globules size. This is due to Ca2+ in RS which reduces or neutralizes 
negative charge of phospholipid so that repulsive force decreases 
between particles and lipid globules coalescence [35].
Human’s blood vessel includes aorta, artery, capillary, venule, vena, and 
vena cava. Smallest human’s blood vessel is 5 µm. Therefore, if the size 
of lipid globules is 5 µm or more, it can cause capillary blockage [36]. 
Safe IV lipid emulsion should have globules size which is lower than 
1 µm. Globules size >1 µm will turn emulsion instable and has potential 
to enlarge above 5 µm and leads to fat embolism, emboli in capillary and 
traps on lung capillary so that it affects respiratory function [35,37].
CONCLUSION
Admixing electrolyte solution (NaCl or RS) and IL in one container or 
through three-way stopcock causes the larger globule size of IL but 
admixing in one container causes larger lipid globule size. Furthermore, 
RS is stronger than NaCl in enlarging lipid globule size.
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